When comparing the differences in gene mutation frequencies between responding and nonresponding patients, we found seven genes to be of interest: mutations in SPTAN1, a gene involved in DDR, and the tumour suppressor gene APC were significantly associated with chemoresistant tumours (p = 0.035 and 0.034, respectively). This evidence concerns the gene SPTAN1 and neoplasm.